| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/28/2009 | US7566817 Glyphosate tolerant alfalfa events and methods for detection |
| 07/28/2009 | US7566816 Generation of plants with altered oil content |
| 07/28/2009 | US7566815 Control of plant flowering time by regulation of phytochrome c expression |
| 07/28/2009 | US7566814 Site-specific recombination in eukaryotes and constructs useful therefor |
| 07/28/2009 | US7566813 Transgenic soybean seeds exhibiting an oil composition comprising 55 to 80% by weight oleic acid, 10 to 40% by weight linoleic acid, 6% or less by weight linolenic acid, and 2 to 8% by weight saturated fatty acids for use in ehancing applicability in food, biodiesel and biolube markets |
| 07/28/2009 | US7566777 Genes encoding hormone and lytic peptides |
| 07/28/2009 | US7566775 N8- and C8-linked purine bases and structurally related heterocycles as universal nucleosides used for oligonucleotides hybridization |
| 07/28/2009 | US7566774 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 07/28/2009 | US7566770 Humanized collagen antibodies and related methods |
| 07/28/2009 | US7566766 Use of phage display libraries in a screening assay in order to determine the identity of peptides sequences which enhance the delivery of the bacteriophage through tissue, such as epithelial cells lining the lumen of gastrointestinal tract |
| 07/28/2009 | US7566765 Heterocyclic compounds containing a nine-membered carbon-nitrogen ring |
| 07/28/2009 | US7566764 Truncated BARD1 protein, and its diagnostic and therapeutic uses |
| 07/28/2009 | US7566703 represents phosphodiester or phosphodiester-like internucleotide linkage; for treating allergy, such as allergic rhinitis and asthma, cancer and hepatitis B and hepatitis C infectious diseases |
| 07/28/2009 | US7566700 siRNA molecules which target the transcription factor STAT6 and repress the expression of STAT6 mRNA, STAT6 protein and STAT6 function in lung cells |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566568 Method for generating highly active human dendritic cells from peripheral blood mononuclear cells |
| 07/28/2009 | US7566567 nontumorigenic, virally-immortalized human hepatocyte cell lines, that can be maintained in serum-free media, and produce endogenous plasma proteins, such as albumin, alpha -1 antitrypsin, blood clotting factors VIII and IX, |
| 07/28/2009 | US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 07/28/2009 | US7566565 eukaryotic cell containing a first expression vector encoding a proprotein of Factor IX (proFIX), or a fusion protein of proFIX, and a second expression vector encoding a functional polypeptide PC5; precursor polypeptide for a Factor IX-Fc monomer-dimer hybrid; culturing |
| 07/28/2009 | US7566561 Alpha-amylase mutants |
| 07/28/2009 | US7566560 Polypeptides and expression vectors host cell and transgenic plants with nucleic acid and stress resistance; antifungal agent |
| 07/28/2009 | US7566559 Human cyclin-dependent kinase (hPNQALRE) |
| 07/28/2009 | US7566558 Polyketide synthetase activity; vectors; host cells |
| 07/28/2009 | US7566557 Genetic engineering; transketolase ; Corynebacterium or Brevibacterium; developed to produce and secrete large amounts of one or more desired fine chemicals |
| 07/28/2009 | US7566552 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/28/2009 | US7566547 Gene 763 of phytopathogenic fungus Magnaporthe grisea and use thereof for identifying fungicidal compounds |
| 07/28/2009 | US7566545 Decreasing blood glucose levels in an animal or for preventing or delaying the onset of a rise in blood glucose levels; improving insulin sensitivity in an animal or for preventing or delaying the onset of insulin resistance; diabetes obesity |
| 07/28/2009 | US7566539 Anti-CCR2 antibodies and methods of use therefor |
| 07/28/2009 | US7566537 Labelled nucleotides |
| 07/28/2009 | US7566535 Enhanced oligonucleotide-mediated nucleic acid sequence alteration |
| 07/28/2009 | US7566457 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans |
| 07/28/2009 | US7566453 Methods for treating melanomas |
| 07/28/2009 | US7566450 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders |
| 07/28/2009 | US7566420 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation |
| 07/28/2009 | CA2356552C New reagent for labelling nucleic acids |
| 07/28/2009 | CA2318726C Ef-tu mrna as a marker for viability of bacteria |
| 07/28/2009 | CA2316447C Rantes mutants and therapeutic applications thereof |
| 07/28/2009 | CA2269088C Method for the production of 1,3-propanediol by recombinant organisms |
| 07/28/2009 | CA2148369C Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof |
| 07/23/2009 | WO2009092042A1 Reprogramming of differentiated progenitor or somatic cells using homologous recombination |
| 07/23/2009 | WO2009092035A2 Methods and compositions for the analysis of biological molecules |
| 07/23/2009 | WO2009092014A1 Enhanced purification of antibodies and antibody fragments by apatite chromatography |
| 07/23/2009 | WO2009092010A1 Enhanced purification of phosphorylated and non-phosphorylated biomolecules by apatite chromatography |
| 07/23/2009 | WO2009092009A2 Modulating light response pathways in plants |
| 07/23/2009 | WO2009092005A2 Methods of generating cardiomyocytes and cardiac progenitors and compositions |
| 07/23/2009 | WO2009091982A1 Mir-122 agonist |
| 07/23/2009 | WO2009091972A2 Chemically modified oligonucleotides and small molecules for use in reducing micro rna activity levels and uses thereof |
| 07/23/2009 | WO2009091904A2 Microrna based methods and compositions for the treatment of cancer |
| 07/23/2009 | WO2009091864A2 Compositions and methods for the suppression of target polynucleotides from lygus |
| 07/23/2009 | WO2009091863A1 Compositions and methods for the suppression of target polynucleotides |
| 07/23/2009 | WO2009091862A2 Compositions and methods for the suppression of target polynucleotides from lepidoptera |
| 07/23/2009 | WO2009091860A2 Compositions and methods for the suppression of target polynucleotides from the family aphididae |
| 07/23/2009 | WO2009091815A2 Methods for modulating de novo hepatic lipogenesis by modulating xbp-1 activity |
| 07/23/2009 | WO2009091810A1 Methods for inhibiting angiogenesis using egfl8 antagonists |
| 07/23/2009 | WO2009091720A2 N-linked glycosylation alteration in e1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 07/23/2009 | WO2009091659A2 Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents |
| 07/23/2009 | WO2009091543A1 An efficient orip/ebna-1 plasmid vector |
| 07/23/2009 | WO2009091228A2 Guanosine monophosphate kinase variant having reduced gmp conversion activity |
| 07/23/2009 | WO2009091141A2 Recombinant microorganism having a producing ability of polylactate or its copolymers and method for preparing polylactate or its copolymers using the same |
| 07/23/2009 | WO2009091074A1 Method for identification of variety of hevea brasiliensis, and kit for identification of variety of hevea brasiliensis |
| 07/23/2009 | WO2009091054A1 Novel hydrogen peroxide-forming nadh oxidase, and dna encoding the same |
| 07/23/2009 | WO2009091053A1 Crystal production method, frozen crystal production method, crystal, crystal structure analysis method, crystallization screening method, and crystallization screening apparatus |
| 07/23/2009 | WO2009091048A1 REACTION JIG, REACTION METHOD AND METHOD OF SYNTHESIZING cDNA |
| 07/23/2009 | WO2009091045A1 Process for production of serine derivative, and protein for use in the process |
| 07/23/2009 | WO2009090933A1 Virus growing in hypoxic cell or virus vector expressing gene therein |
| 07/23/2009 | WO2009090787A1 Method for producing bioactive peptide or protein and recombinant animal cell |
| 07/23/2009 | WO2009090554A2 Specific aptamers generated for suppression of cell migration and invasion by cancer cells, methods of selection for such aptamers and their usage |
| 07/23/2009 | WO2009090284A1 Method for creating a combinatorial population of transgenic plants which express and gather together diverse valuable metabolites |
| 07/23/2009 | WO2009090190A1 Mouse models carrying a knock-out mutation of the glutaminyl cyclase gene |
| 07/23/2009 | WO2009090182A1 C4'-substituted - dna nucleotide gapmer oligonucleotides |
| 07/23/2009 | WO2009089928A1 Maize plants characterised by quantitative trait loci (qtl) |
| 07/23/2009 | WO2009089846A1 Methods for increasing the therapeutic efficacy of immunoglobulin g class 3 (igg3) antibodies |
| 07/23/2009 | WO2009089678A1 Scirr10 neurotrophic factor, its receptor and uses thereof |
| 07/23/2009 | WO2009089630A1 Cellulase variants with reduced inhibition by glucose |
| 07/23/2009 | WO2009089620A1 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
| 07/23/2009 | WO2009089605A1 Recombinant viral vectors and vaccine composition for leishmaniasis |
| 07/23/2009 | WO2009073605A3 Drought tolerant plants and related constructs and methods involving genes encoding ferrochelatases |
| 07/23/2009 | WO2009071680A3 Rna antagonist compounds for the modulation of mcl-1 |
| 07/23/2009 | WO2009068033A3 Lna antagonists targeting the androgen receptor |
| 07/23/2009 | WO2009064255A8 N-terminal xa27 signal anchor and its use for localization of fusion proteins |
| 07/23/2009 | WO2009063198A3 Extraction and purification of biological cells using ultrasound |
| 07/23/2009 | WO2009061442A8 Method to produce induced pluripotent stem (ips) cells form non-embryonic human cells |
| 07/23/2009 | WO2009056566A3 Plants having enhanced yield-related traits and a method for making the same |
| 07/23/2009 | WO2009051662A3 Lunasin-induced regulation of disease-related gene expression |
| 07/23/2009 | WO2009020848A8 RNAI-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 07/23/2009 | WO2009020847A3 Rnai-related inhibition of tnfa signaling pathway for treatment of ocular angiogenesis |
| 07/23/2009 | WO2009017692A3 Vectors and methods for cloning gene clusters or portions thereof |
| 07/23/2009 | WO2009014462A8 Methods and polynucleotides for improving plants |
| 07/23/2009 | WO2009007091A3 Brassica plant comprising mutant fatty acyl-acp thioesterase alleles |
| 07/23/2009 | WO2008151639A3 Oligonucleotides for modulation of target rna activity |
| 07/23/2009 | WO2008142693A8 Regulation of myelination by nectin-like (necl) molecules |
| 07/23/2009 | WO2008136748A8 Tumour growth inhibitory compounds and methods of their use |
| 07/23/2009 | WO2008127193A8 Metalled sirnas for facilitated targeting of suboptimal mrna sequences |
| 07/23/2009 | WO2008127179A8 Fusion protein vaccine |
| 07/23/2009 | WO2008119571A3 Nucleic acid myostatin antagonist aptamers obtained by (mirror- image) selex |
| 07/23/2009 | WO2008114282A8 Transgenic rice (oryza sativa) comprising pe-7 event and method of detection thereof |
| 07/23/2009 | WO2008091352A8 Indicator cell lines and methods for making same |
| 07/23/2009 | WO2008091311A8 Transgene expression in avians |
| 07/23/2009 | WO2008091154A8 Use of r-genes as a selection marker in plant transformation and use of cisgenes in plant transformation |
| 07/23/2009 | WO2008091153A8 A functional r-gene from solanum bulbocastanum |